Every material Form 8-K TCGX Acquisition Corp. II has filed with the SEC since October 19, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
TCGX Acquisition Corp. II, a blank-check SPAC, closed its initial public offering of 10,000,000 Class A ordinary shares at $10.00 per share, raising $100,000,000 in gross proceeds, and placed the full amount in a U.S. trust account. The company will seek a business combination, with a focus on healthcare and healthcare-related industries, and shareholders' redemption rights depend on whether it completes a deal within 24 months.
IPO of 10,000,000 Class A ordinary shares at $10.00 per share, closed October 19, 2026, for $100,000,000 in gross proceeds
Concurrent private placement of 450,000 shares to the sponsor at $10.00 per share, for $4,500,000
$100,000,000 placed in a trust account at Citibank, N.A.; funds are generally held until a business combination or redemption if none is completed within 24 months
Shares to trade on Nasdaq Capital Market under ticker TCXB beginning October 16, 2026; investors receive no warrants
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every TCGX Acquisition Corp. II filing is on SEC EDGAR ↗. 8-K briefs of other companies →